BR PHARM - CAI Pharmaceuticals

Bio-pharmaceutical company
with expertise of regenerative medicine



Raw material of medicine (PDRN) of BR Pharm is a product listed on DMF.

The materials are certified of BGMP (Biological Good Manufacturing Practices).

About BR Pharm

BR Pharm performs research activities of wide scope of regenerative medicine technologies for the purpose of ensuring comfort and pleasant lives based on core technologies by making use of PDRN.

BR Pharm owns manufacture technology of cell cycling activator of PDRN medicine for producing regenerative medicine, and listed raw material medicine (PDRN) on DMF, and is certified of BGMP (Bulk Good Manufacture Practice) by the Ministry of Food and Drug Safety. Further, BR Pharm cooperates governmental institutes for consumption and supply of safe PDRN raw material medicine.


VISION

Creating knowledge by sharing sensitiveness through streamlined communication

HISTORY

  • 2023

    Small and Medium Venture Business Technology Innovative Small and Medium Business Innobiz Certification - 04
  • 2022

    12 - 2022 Gangwon-do Job Grand Prize
    08 - Selected as a 2022 bio star company IPO support project
    04 - 2022 Korea Medical Healthcare Awards - PN joint cavity injection division
    02 - Domestic approval of HP VITARAN J (No. 22-99)
  • 2021

    Domestic approval of Revitrane HA10 (No. 21-1003) - 12
  • 2020

    10 - Gangwon Intellectual Property Man of Merit Award
    03 - Business compliant with Korea Good Manufacturing Practice (Major category of GMP - Injections)
  • 2019

    Certified of venture business (R&D business) by Kora SME's and Startups Agency - 06
    Elected of one of participant companies in Export Voucher Project (Growth) - 03
    Issued of Certificate of GMP Compliance of a Manufacturer by Seoul Regional Food and Drug Administration
    Listed PDRN raw material medicine on DMF (Drug Master File) - 01
  • 2018

    12 - Won three million Dollar's export award
    05 - Elected of one of participant companies in the export promising project of the export company technology development tasks (Government contribution of 600 million KRW/May 1, 2018 - Apr. 30, 2020)
    03 - Elected of IP Star Business
    02 - Judged of success of achievement of creative combination R&D project - Ministry of Trade, Industry and Energy
    01 - Certified of Main-Biz
  • 2017

    Certified of GMP Compliance of a Manufacturer for Factory II Certified of European CE of HA filler Issued of compliance certificate of Cosmetics Good Manufacture Practice (CGMP) - 12
    Elected of one of participant companies in Export Competence Enhancement Project of companies of high growth rate by Small and Medium Business Corp.
    Certified of ISO 22716 (NO. 820210)-Manufacture of mask packs, toners, cream and essences - 09
  • 2016

    12 - Completed construction of Factory II and moved the head office (13, Sinpyeong-ro inside Business Town, Wonju-si, Gangwon-do) Won a special award of 20th Gangwon Small Business Concluded MOU with Goheung-gun, Jeollanam-do
    09 - Seo Pyeong-sun , CEO, resigned, and Kim Seok-sun, new CEO, took office
    07 - Concluded MOU with Institute of Ocean & Fisheries Technology of Jeollanam-do
    05 - Elected of one of participant companies in the export competence enhancement project, and overseas standard certification support project for companies of high-growth level - Small and Medium Business Corp.
    03 - Certified of ISO13485 (No. 820083) - Development, Manufacture of Hyaluronic Acid Gel, PDRN (Polydeoxyribonucleotide) Gel
    02 - Certified of GMP Compliance of a Manufacturer of medical devices for Factory II (in the general support center of medical devices)
  • 2015

    Certified of ISO13485 (No. 820083) - Development, Manufacture of Hyaluronic Acid Gel - 12
    Changed the company name to BR Pharm - 06
  • 2005

    BR Beautiful Revolution established (CEO Seo Pyeong-sun) - 07

PRODUCTS HP CELL VITARAN i